Affordable Access

Autologous bone marrow transplantation for CML in which retroviral markers are used to discriminate between relapse which arises from systemic disease remaining after preparative therapy versus relapse due to residual leukemia cells in autologous marrow: a pilot trial. The University of Texas M.D. Anderson Cancer Center.

Type
Published Article
Journal
Human gene therapy
Publication Date
Volume
2
Issue
4
Pages
359–376
Identifiers
PMID: 1665350
Source
Medline

Statistics

Seen <100 times